Brief: Heidelberg Pharma Adjusts 2020 Guidance

Heidelberg Pharma AG

29/09/2020 10:05

Sept 29 (Reuters) - HEIDELBERG PHARMA AG  HPHA.DE :
    * ANNOUNCES ADJUSTMENT OF GUIDANCE
    * EXPECTS FY OPERATING EXPENSES BETWEEN EUR 26.0 MILLION AND
EUR
28.0 MILLION (PREVIOUSLY: EUR 20.0 MILLION TO EUR 24.0 MILLION
    * FY SALES AND OTHER INCOME WILL CONTINUE TO RANGE BETWEEN
EUR 9.0
MILLION AND EUR 10.0 MILLION (PREVIOUSLY: EUR 8.0 MILLION TO EUR
10.0 MILLION).
    * BASED ON THESE ADJUSTMENTS, FY OPERATING RESULT (EBIT)
BETWEEN
EUR -16.0 MILLION AND EUR -19.0 MILLION IS EXPECTED (PREVIOUSLY:
EUR -11.0 MILLION TO EUR -15.0 MILLION).
    * FOR 2020, HEIDELBERG PHARMA ANTICIPATES CASH REQUIREMENTS
OF EUR
18.0 MILLION TO EUR 20.0 MILLION (PREVIOUSLY: EUR 11.0 MILLION
TO EUR 15.0 MILLION)
    * 2020 MONTHLY CASH CONSUMPTION IS EXPECTED TO RANGE BETWEEN
EUR
1.5 MILLION AND EUR 1.7 MILLION PER MONTH (PREVIOUSLY: EUR 0.9
MILLION AND EUR 1.3 MILLION)
    * FINANCING IS STILL SECURED UNTIL MID-2021.

Source text for Eikon:  ID:nEQ9SWwtZa 
Further company coverage:  HPHA.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))